Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-10-06Clinical Trial Update: Study of a Neurocognition Enhancing Agent in Patients With Schizophrenia [Phase 2, Phase 3]
A Phase 2/Phase 3 study evaluating a neurocognition enhancing agent for schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2011-10-04Clinical Trial Update: Comparison of Paliperidone Palmitate and RISPERDAL CONSTA in Patients With Schizophrenia [Phase 3]
A Phase 3 head-to-head trial comparing paliperidone palmitate with RISPERDAL CONSTA in adults with schizophrenia has completed, with results…
-
CLINICAL_TRIALS trial_result · 2011-09-23Clinical Trial Update: Non-interventional Open Label Study to Investigate the Effect of Quetiapine XR on Patient Satisfaction and Quality of Life in Patients With Schizophrenia
A completed non-interventional, open-label study evaluating the effect of Quetiapine XR on patient satisfaction and quality of life in peopl…
-
CLINICAL_TRIALS trial_result · 2011-09-20Clinical Trial Update: The CAMPUS Project: Cholinergic Augmentation of Cognitive Deficits in Schizophrenia [Phase 2]
The CAMPUS Project, a Phase 2 trial evaluating cholinergic augmentation of cognitive deficits in schizophrenia, has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-09-19Clinical Trial Update: Dopaminergic, Functional, Structural, and Cognitive Disturbances in First-episode Schizophrenia [NA]
This entry reports the completion of a clinical trial examining dopaminergic, functional, structural, and cognitive disturbances in individu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-09-16Clinical Trial Update: Aripiprazole in the Treatment of Patients With Schizophrenia and Symptoms of Obsessive Compulsive Disorder (OCD) [NA]
A completed clinical trial evaluated aripiprazole for patients with schizophrenia who also exhibit obsessive-compulsive symptoms.
-
CLINICAL_TRIALS trial_result · 2011-09-08Clinical Trial Update: The Bioequivalence Of Two Different Lurasidone Formulations In Patients [Phase 1]
Phase 1 study comparing the bioavailability of two lurasidone formulations in patients with schizophrenia to determine equivalence.
-
CLINICAL_TRIALS trial_result · 2011-09-08Clinical Trial Update: Midazolam Drug-Drug Interaction Study With Lurasidone HCl [Phase 1]
Phase 1 study completed to evaluate the pharmacokinetic interaction and safety between midazolam and lurasidone hydrochloride in schizophren…
-
CLINICAL_TRIALS trial_result · 2011-09-08Clinical Trial Update: Digoxin Drug-Drug Interaction With Lurasidone HCl [Phase 1]
Phase 1 study evaluating the potential drug-drug interaction between digoxin and lurasidone hydrochloride in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2011-09-08Clinical Trial Update: Lithium Drug-Drug Interaction Study With Lurasidone HCl [Phase 1]
The Phase 1 trial update reports completion of a lithium and lurasidone hydrochloride drug-drug interaction study in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2011-09-08Clinical Trial Update: Effect of Calories and Fat Content on the Pharmacokinetics of Lurasidone HCl [Phase 1]
This completed Phase 1 pharmacokinetic study investigates how calorie intake and fat content influence the absorption and exposure of lurasi…
-
CLINICAL_TRIALS trial_result · 2011-09-07Clinical Trial Update: Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (BMS) [NA]
A terminated clinical trial evaluated cognitive outcomes with aripiprazole (Abilify) in patients with schizophrenia (also including schizoaf…
-
CLINICAL_TRIALS trial_result · 2011-09-07Clinical Trial Update: Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI) [NA]
A terminated clinical trial evaluated cognitive outcomes with aripiprazole (Abilify) in patients with schizophrenia and schizoaffective diso…
-
CLINICAL_TRIALS trial_result · 2011-09-02Clinical Trial Update: PHARMO Institute Seroquel Safety Study
A completed PHARMO Institute safety study evaluating Seroquel (quetiapine) across schizophrenia, major depressive disorder, bipolar disorder…
-
CLINICAL_TRIALS trial_result · 2011-08-19Clinical Trial Update: Effects of 'Seroquel-XR' on the Improvement of Neurocognitive Function in People At-risk Mental States(ARMS) [Phase 4]
A Phase 4 clinical trial evaluates whether Seroquel-XR (quetiapine extended-release) improves neurocognitive function in people at risk for …
-
CLINICAL_TRIALS trial_result · 2011-08-18Clinical Trial Update: Effectiveness of Atypical Antipsychotics on Anhedonic Features in Patients With Schizophrenia
A clinical trial evaluated the effectiveness of atypical antipsychotics on anhedonic features in schizophrenia patients. The trial status is…
-
CLINICAL_TRIALS trial_result · 2011-08-02Clinical Trial Update: Omega-3 Fatty Acid Deficiency Replacement in Early Schizophrenia [Phase 2, Phase 3]
A completed Phase 2/Phase 3 clinical trial evaluating omega-3 fatty acid deficiency replacement in early schizophrenia, sponsored by the Uni…
-
CLINICAL_TRIALS trial_result · 2011-08-01Clinical Trial Update: Safety Study of Sertindole Versus Risperidone Under Normal Conditions of Use [Phase 3]
Phase 3 safety study comparing sertindole with risperidone under normal conditions of use in schizophrenia; results were posted.
-
CLINICAL_TRIALS trial_result · 2011-07-29Clinical Trial Update: Effect of Ziprasidone on Glucose & Plasma Lipids in Diabetes (II) and Schizophrenia or Schizoaffective Disorder [Phase 2, Phase 3]
The document reports on a clinical trial studying how ziprasidone affects glucose and lipid parameters in people with diabetes and in those …
-
CLINICAL_TRIALS trial_result · 2011-07-28Clinical Trial Update: Magnetic Stimulation as a Treatment for Auditory Hallucinations in Schizophrenia [Phase 4]
This clinical trial update reports a Phase 4 investigation of magnetic stimulation for treating auditory hallucinations in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism [Phase 4]
A Phase 4 trial compares chronic olanzapine versus risperidone and assesses their effects on glucose and lipid metabolism in schizophrenia p…
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: Treatment Strategy for Refractory Schizophrenia: Drug Interaction Between Clozapine and Fluvoxamine [Phase 4]
Phase 4 clinical trial evaluating the interaction between clozapine and fluvoxamine in treatment-refractory schizophrenia. The study highlig…
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients
Completed clinical trial evaluating how atypical antipsychotics influence appetite and eating behavior in people with schizophrenia and schi…
-
CLINICAL_TRIALS trial_result · 2011-07-21Clinical Trial Update: Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic Syndrome [Phase 3]
Phase 3 trial comparing aripiprazole with standard of care on non-HDL cholesterol in adults with schizophrenia or bipolar I disorder and met…
-
CLINICAL_TRIALS trial_result · 2011-07-13Clinical Trial Update: A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder [Phase 4]
Phase 4 trial update assessing cataract risk associated with quetiapine (Seroquel) and risperidone (Risperdal) in people with schizophrenia …